Cohance Lifesciences Ltd share price logo

Cohance Lifesciences Ltd

NSE: COHANCE

BSE: 543064

Small Cap

Pharma Sector

₹431.35

+7.75

(+1.83%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Cohance Lifesciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-11%

Searches for Cohance Lifesciences on INDmoney have decreased by 11% over the last 30 days.

Investment activity on INDmoney

-8.65%

Investment activity in Cohance Lifesciences among INDmoney users has decreased by 8.65% over the last 30 days.

Average holding period of indmoney investors

18 days

INDmoney investors hold Cohance Lifesciences shares for an average of 18 days.

Key Events for Cohance Lifesciences

Last Dividend Declared

₹5.00 per share, declared on 02/09/2022

View Dividend History

Cohance Lifesciences Stock Performance

as on September 16, 2026 at 6:28 pm IST

  • Day's Low

    Day's High

    ₹416.20
    ₹431.95
    downward going graph

    3.51%

    Downside

    0.14%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹266.70
    ₹1,008.70
    downward going graph

    38.17%

    Downside

    133.85%

    Upside

    downward going graph

Cohance Lifesciences share price movements today

Previous Close
₹423.60
Open
₹431.65
Volume
2.19L
Upper Circuit
₹508.30
Lower Circuit
₹338.90
Day's Low - High
₹416.20 - ₹431.95
52 Week Low - High
₹266.70 - ₹1,008.70

Cohance Lifesciences Historical Returns

1 Month Return
-4.76 %
3 Month Return
-2.04 %
1 Year Return
-57.24 %
3 Year Return
-23.59 %
5 Year Return
-21.27 %

Cohance Lifesciences Fundamentals

as on September 16, 2026 at 12:58 pm IST

Market Cap

₹16,206.82 Cr

Return on Equity (ROE)

5.23

PE Ratio (TTM)

158.35

Return on capital employed (ROCE)

7.31

Industry PE ratio

51.81

Beta (LTM)

0.83

P/B Ratio

2.58

Dividend Yield

0

PEG Ratio

-17.01

Quarterly Earnings Growth YOY

-197.39

EPS (TTM)

3.92

Book Value

102.23

Cohance Lifesciences Stock Valuation

as on September 16, 2026 at 12:58 pm IST

Cohance Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (4.48x)

March 30, 2020

Industry (51.81x)

September 11, 2026

Today (158.35x)

September 11, 2026

Highest (171.06x)

August 20, 2026

LowHigh

Today’s Price to Earnings Ratio: 158.35x

Cohance Lifesciences Technical Analysis

Track how Cohance Lifesciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish14
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.07
Bullish
CCI (20)
-655.26
Bullish
RSI (14)
60.19
Neutral
Momentum (10)
0.2
Bullish
ADI (14)
40.16
Bullish
Ultimate Oscillator (7,14,28)
90.75
Bullish

Moving Averages

Name

Value

Action

SMA (20)
431.49
Bullish
EMA (20)
431.47
Bullish
VWMA (20)
431.48
Bullish
SMA (50)
431.32
Bullish
EMA (50)
431.21
Bullish
SMA (200)
428.02
Bullish
EMA (200)
429.02
Bullish
KAMA (200)
431.01
Bullish
DEMA (200)
430.83
Bullish

Cohance Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cohance Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,206.82-4.25%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,120.3612.3%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,101.01-7.47%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,764.7444.58%0.682811,703
Poly Medicure Ltd image
Poly Medicure Ltd
BUY17,278.0815.65%0.573201,875
See all

Market expectation of Cohance Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

37.50%

Buy

12.50%

Hold

50.00%

Sell

Cohance Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
231.05
219.82
252.93
488.08
603.77
676.23
840.42
549.31
555.57
544.55
619.12
422.26
Other Income
19.84
14.34
17.05
19.41
16.19
21.56
12.05
14.17
15.6
6.16
-1.84
12.25
Total Income
250.9
234.16
269.98
507.49
619.96
697.79
852.47
563.48
571.17
550.71
617.28
434.51
Expenses
133.09
153.74
179.59
362.98
398.4
438.86
626.98
445.4
434.62
454.06
536.95
421.1
Operating Profit
97.96
66.08
73.34
125.1
205.37
237.37
213.44
103.91
120.95
90.49
82.17
1.16
Operating Profit Margin %
42.4%
30.06%
29%
25.63%
34.01%
35.1%
25.4%
18.92%
21.77%
16.62%
13.27%
0.27%
Profit Before Interest, Tax and Depreciation
117.8
80.42
90.4
144.51
221.56
258.93
225.49
118.08
136.55
96.65
80.33
13.41
Interest
0.5
2.16
2.3
10.2
9.61
10.8
10.45
10.18
8.76
9.11
9.19
6.74
Depreciation
11.89
12.79
17.25
31.28
37.79
43.56
54.17
45.14
44.02
46.94
51.23
49.54
Profit Before Tax
105.41
65.47
70.85
103.03
174.16
204.57
160.87
62.76
83.77
40.6
19.91
-42.87
Tax Paid
25.84
18.72
17.48
27.66
35.92
51.09
43.72
16.36
17.38
11.58
11.6
2.32
Profit After Tax
79.56
46.75
53.37
75.37
138.24
153.48
117.15
46.4
66.39
29.02
8.31
-45.19
Total Net profit including share of profit / Loss from associate company
79.56
46.75
53.37
75.37
138.24
153.48
117.15
46.4
66.39
29.02
8.31
-45.19
EPS
3.13
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Actual EPS
3.13
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Adjusted EPS
3.13
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Diluted EPS
3.13
1.84
2.1
1.97
3.61
4.01
3.1
1.27
1.93
0.96
0.5
-0.65

Cohance Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
377.83
833.79
1,009.72
1,320.22
1,340.33
1,051.35
2,608.5
2,268.55
Other Income
0.6
66.33
67.97
133.49
46.36
61.91
69.21
34.09
Total Income
378.43
900.12
1,077.69
1,453.71
1,386.69
1,113.26
2,677.71
2,302.64
Expenses
206.28
452.19
569.24
740.8
766.17
645.54
1,827.22
1,871.03
Operating Profit
171.55
381.6
440.48
579.42
574.16
405.81
781.28
397.52
Operating Profit Margin %
45.4%
45.77%
43.62%
43.89%
42.84%
38.6%
29.95%
17.52%
Profit Before Interest, Tax and Depreciation
172.15
447.93
508.45
712.92
620.53
467.72
850.49
431.61
Interest
2.79
19.92
9.14
6.23
12.81
7.45
41.06
37.24
Depreciation
11.5
23.51
31.64
39.1
47.99
54.6
166.8
187.33
Profit Before Tax
157.86
404.5
467.67
667.59
559.73
405.67
642.63
207.04
Tax Paid
48.59
87.51
105.34
213.78
148.44
105.39
158.39
56.92
Profit After Tax
109.27
317
362.34
453.8
411.29
300.28
484.24
150.12
Total Net profit including share of profit / Loss from associate company
109.27
317
362.34
453.8
411.29
300.28
484.24
150.12
EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
4.69
Actual EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
4.69
Adjusted EPS
4.3
12.46
14.23
17.83
16.16
11.8
12.79
4.69
Diluted EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.68
4.68

Cohance Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
50.4
406.92
382.55
330
457.2
358.48
673.35
368.32
Cash Flow from Investing Activities
-65.48
-413.46
-311.41
-136.21
-195.01
-362.26
-387.62
-250.68
Cash Flow from Financing Activities
25.97
7.33
-75.67
-156.42
-241.96
-13.8
-327.4
-165.15
Net Cash Flow
10.9
0.79
-4.51
37.38
20.24
-17.57
-41.67
-47.51

Cohance Lifesciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
May 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
60%
50.1%
50.1%
50.1%
50.1%
50.1%
66.41%
66.41%
57.49%
57.49%
57.49%
57.49%
DII
15.94%
17.24%
17.42%
16.94%
16.68%
16.6%
11.02%
11.4%
20.82%
21.57%
21.79%
20.09%
FII
10.14%
9.54%
9.8%
10.7%
10.84%
11.05%
7.38%
7.23%
6.51%
6.02%
5.59%
6.5%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
13.91%
23.1%
22.67%
22.25%
22.37%
22.23%
15.18%
14.95%
15.17%
14.92%
15.12%
15.92%
Total Outstanding Shares
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
Total Shareholders
70,052
68,932
65,777
69,337
84,210
86,325
88,658
80,910
75,284
81,877
85,230
99,149

Mutual Funds Buying / Exiting Cohance Lifesciences

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Cohance Lifesciences

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Invesco India Contra Fund Direct Plan Growth

Invesco India Contra Fund Direct Plan Growth

₹189.52 Cr

₹16.14 Cr (+9.31%)

0.97%

Mutual Funds Exiting Cohance Lifesciences

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Cohance Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Cohance Lifesciences.

  • Cohance Lifesciences Ltd Earnings Results

    Cohance Lifesciences Ltd’s net profit fell -149.35% since last year same period to ₹-24.12Cr in the Q1 2026-2027. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -223.38% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Cohance Lifesciences Ltd Dividends September,2022

    In the quarter ending June 2022, Cohance Lifesciences Ltd has declared dividend of ₹5.00 per share on 02 Sep 2022 - translating a dividend yield of 2.50%.

    Read More about Dividends

Indices Featuring Cohance Lifesciences Stock

Check stock indices that include Cohance Lifesciences.

Nifty Small 100

₹19,381.45

-41.00 (▲0.21%)

Nifty MNC

₹31,172.20

+134.70 (▲0.43%)

S&P BSE SmallCap Select

₹8,968.80

+1.74 (▲0.02%)

Nifty Smallcap 50

₹9,704.40

-9.30 (▲0.10%)

S&P BSE 400 MidSmallCap

₹12,396.87

-9.97 (▲0.08%)

BSE Healthcare

₹50,323.67

-155.14 (▲0.31%)

Nifty Smallcap 250

₹17,852.10

-40.70 (▲0.23%)

Nifty 500

₹22,541.00

+63.55 (▲0.28%)

S&P BSE 250 SmallCap

₹7,040.28

-12.34 (▲0.17%)

Nifty MidSmallcap 400

₹20,724.05

-26.65 (▲0.13%)

BSE 500

₹35,272.74

+103.12 (▲0.29%)

Insights on Cohance Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 15.12% to 15.92% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.59% to 6.50% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 181.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 57.49% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 108.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 18.57% to 18.21% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 74.08 Cr → -24.12 Cr (in ₹), with an average decrease of 106.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, COHANCE stock has moved down by -57.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 617.28 Cr → 434.51 Cr (in ₹), with an average decrease of 29.6% per quarter

About Cohance Lifesciences Ltd

Suven Pharmaceuticals Limited (SPL) is a biopharmaceutical company engaged in the development and manufacturing of New Chemical Entity (NCE) based Intermediates and Active Pharmaceutical Ingredients, Speciality Chemicals, and formulated drugs. In 2019, Suven Life Sciences Ltd. transferred the CRAMS business to the Company, and the equity shares of the Company were listed for trading in March 2020. The Board approved and recommended the issue of 1:1 bonus shares in August 2020, and the number of shares increased from 127,282,478 to 254,564,956. In 2021, Suven invested 120 crore in investing and has a capex plan of Rs.320crore. In 2022, the Company also filed 17 ANDAs for which 9 were approved and 8 products were launched. The Company acquired 100 stake in Casper Pharma Private Limited in 2022, making it a Wholly Owned Subsidiary. In this way, Suven Pharmaceuticals Limited is endeavouring to be the leading biopharmaceutical company in global markets.

Revenue: ₹422.26Cr as on June 2026 (Q1 FY27)
Net Profit: ₹-45.19Cr as on June 2026 (Q1 FY27)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
OrganisationCohance Lifesciences Ltd
IndustryPharmaceuticals
CEOAnnaswamy Vaidheesh
E-voting on sharesClick here to vote

FAQs

What is Cohance Lifesciences share price today?

Cohance Lifesciences share price today stands at ₹431.35 as on . Cohance Lifesciences share today touched a day high of ₹431.95 and a low of ₹416.2.

What is the 52 week high and 52 week low range for Cohance Lifesciences share?

Cohance Lifesciences touched a 52 week high of ₹1008.7 and a 52 week low of ₹266.7. Cohance Lifesciences share price today i.e. is trending at ₹431.35, which is -57.24% down from its 52 week high and 61.74% up from its 52 week low.

What is Cohance Lifesciences's market capitalisation today?

Cohance Lifesciences market capitalisation is ₹16,206.82 Cr as on .

How to buy Cohance Lifesciences shares?

To buy Cohance Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for COHANCE or Cohance Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Cohance Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Cohance Lifesciences trading volume today?

Cohance Lifesciences trading volume is 2.19L as on . This means that 2.19L shares of Cohance Lifesciences were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Cohance Lifesciences shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Cohance Lifesciences have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 18 days. This reflects platform activity only and is not investment advice.